tirzepatide alternatives 2025 Eli Lilly sues companies selling alternative versions of its weight loss drug : Shots The weight-loss drugs being tested

Novo Nordisk has registered exploratory pharmacokinetic studies for semaglutide in younger pediatric cohorts, but no Phase 3 efficacy or safety trial in children aged 6 to 11 has reported results as of May 2026

The half-life for you may be somewhat different from the average, based on these factors

However, these compounded medications lack FDA approval, meaning they havent undergone the same rigorous clinical testing as branded options like Mounjaro or Zepbound

Dehydration is the most common concern with Jardiance, particularly during illness, hot weather, or when combined with other medications that affect fluid balance

Self-switching is not advised due to regulatory and therapeutic considerations

Both Ruhoy and Kaufman appear to have glommed onto these drugs via the 700-plus doctors MASTERMINDS network of health providers in communication with each other about ME/CFS, FM, MCAS, POTS, long COVID, etc